HIV Drugs Market Growth, Innovations and Market Size Forecast 2035
According to forecasts, the global HIV drugs market size will grow from USD 34.75 billion in 2026 to USD 52.95 billion by 2035, with an expected CAGR of 4.3%. In 2025, combination-class drugs led the HIV drugs market with a 60% share, while hospital pharmacies dominated distribution at 50%. North America was the top region. Key players include ViiV Healthcare, Gilead, Janssen, Roche, Mylan, Theratechnologies, Boehringer Ingelheim, Cipla, Teva and Merck.
Last Updated : 05 August 2026Category: Therapeutic AreaInsight Code: 5131Format: PDF / PPT / Excel
South America HIV Drugs Market Size Value (US$) and Volume (Billion Tons), by Distribution Channel (2021 – 2033)
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Company Profiles
ViiV Healthcare
Company Overview
Geographic Footprints
Financial Performance
Product Portfolio
SWOT Analysis
R&D Efforts
Recent Developments & Strategic Collaborations
Product Launch/M&A/Technical Collaboration
Gilead Sciences, Inc.
Janssen Pharmaceuticals, Inc.
F. Hoffmann-La Roche Ltd.
Mylan Pharmaceuticals Inc.
Theratechnologies Inc.
Boehringer Ingelheim International GmbH
Cipla Ltd.
Teva Pharmaceutical Industries Ltd.
Merck & Co., Inc.
Conclusion & Recommendations
FAQ's
Answer : HIV drugs market stands at USD 37.81 billion in 2026 and is expected to reach USD 55.23 billion by 2035, growing at a CAGR of 4.30% from 2026 to 2035.
Answer : North America, particularly the United States, leads the market for HIV drugs due to factors such as high healthcare spending, robust research and development infrastructure, and widespread access to treatment and care services.
Answer : World Health Organization, HHS.gov., Centers for Disease Control and Prevention, HIV.gov., National Institute of Health
Payal Rabde is a Healthcare Market Research Analyst at Towards Healthcare Research & Consulting with 4+ years of experience in pharmaceuticals, biotechnology, medical devices, and life sciences.
Aditi Shivarkar is a seasoned professional with over 14 years of experience in healthcare
market research. As a content reviewer, Aditi ensures the quality and accuracy of all market
insights and data presented by the research team.
We use cookies that are necessary to make our site work. We may also use additional cookies to analyze,
improve, and personalize our content and your digital experience.
You can manage your cookie preferences using the
Privacy Policy
For more information, see our
Terms and Conditions
.
Cookie Preference Center
We use cookies which are necessary to make our site work.
We may also use additional cookies to analyze, improve and personalize
our content and your digital experience.
For more information, please read our
Cookie Policy
.
You may choose not to allow some types of cookies.
Blocking some cookies may impact your experience of the site.
sales@towardshealthcare.com
+1 804-441-9344
Download Sample
USA : +1 8044 419344
sales@towardshealthcare.com